Figure Asset: Outlook Therapeutics Faces Pivotal FDA Decision on Eye Drug Application
| Source Document | Outlook Therapeutics |
|---|---|
| Rights Usage | Educational / Academic Use Permitted |
| Format Type | Digital Image (JPEG/PNG/WEBP via proxy) |
| Source Document | Outlook Therapeutics |
|---|---|
| Rights Usage | Educational / Academic Use Permitted |
| Format Type | Digital Image (JPEG/PNG/WEBP via proxy) |